Exton, PA and San Diego, CA – February 3, 2021 – Immunome, Inc. (Nasdaq: IMNM), a biopharmaceutical company utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics, and Abzena, a partner research organization for integrated discovery to cGMP manufacturing solutions for biologics, today announced that Abzena was selected as Immunome’s […] Read more

Abzena, a Global Partner Research Organization for integrated bench to market solutions for biologics and bioconjugates, has announced the addition of a 6th Global site that will augment cGMP manufacturing capacity for mammalian biologics. This expansion is driven by an increase in customer demand for commercial scale 2000L single use bioreactors across a wide range […] Read more

Abzena, a Global Partner Research Organization for integrated bench to bedside solutions for biologics, complex chemistry and bioconjugates, has appointed Kimball Hall, Chief Operating Officer at Abzena as President in addition to her COO role. As part of the promotion, Kimball has also been added to the Company Board. The promotion recognizes Ms. Hall’s pivotal […] Read more

Abzena, a global partner research organization for integrated bench to market solutions for biologics and bioconjugates, has announced upgrades of its chemistry GMP suites. The Bristol PA site manufacturing facility upgrades allow Abzena’s ADC client projects to seamlessly progress from discovery to commercial without technology transfer. The Bristol site enhancements includes two new GMP suites, […] Read more

Leading contract provider of integrated discovery, development and manufacturing services for biologics and bioconjugates, Abzena, has invested $60m into a new facility for late phase and commercial cGMP manufacturing. The new ~50,000 sqft ‘Lusk’ facility, at the company’s site in San Diego, CA, US, houses a process development laboratory and two new cGMP manufacturing cleanrooms for […] Read more

Cambridge, UK and San Diego, CA,  October 5,  2020 – Abzena, a leading Partner Research Organization (PRO) for biopharmaceutical outsourced solutions from concept to clinic and into GMP manufacturing has announced the appointment of Giovanni Escobar as Senior Vice President (SVP) and Site Head of its Bristol Operations. With over 27 years’ experience in the Pharmaceutical […] Read more

Cambridge, UK and San Diego, CA, 17th September 2020 – Abzena, a fully integrated global development and GMP manufacturing partner for the biopharmaceutical industry, has been announced as the winner of the Best Contract Research (CRO) category at the World ADC Awards 2020. The World ADC awards recognise innovation, leadership and devotion in the field of ADCs and […] Read more

Cambridge, UK and San Diego, CA, 18 August 2020 – Abzena, a leading Partner Research Organization (PRO) for biopharmaceutical outsourced solutions from concept to clinic and into GMP manufacturing has announced the appointment of Anu Bansal as Senior Director of Manufacturing at its facility in Bristol, Pennsylvania. With more than 20 years in the biopharmaceutical industry, […] Read more

Cambridge, UK and San Diego, CA, 3 August 2020 – Abzena, a leading Partner Research Organization (PRO) for biopharmaceutical outsourced solutions from concept to clinic and into GMP manufacturing has announced the appointment of Matthew LeClair as Senior Vice President (SVP) and Site Head of its San Diego Operations. With more than 29 years’ experience in the […] Read more

Cambridge, UK, Bristol, PA and San Diego, CA — 28 July 2020 — Abzena, a leading global partnership research organization providing integrated discovery, development and manufacturing of biologics and antibody drug conjugates (ADCs), has announced a $10M investment of growth capital from Biospring Partners, a New York based investment firm. The new capital will allow […] Read more